# SMOFlipid and Incidence of BPD in Preterm Infants

> **NCT04078906** · NA · UNKNOWN · sponsor: **University of Calgary** · enrollment: 384 (estimated)

## Conditions studied

- Very Low Birth Weight Infant
- Bronchopulmonary Dysplasia

## Interventions

- **OTHER:** n3-LCPUFA enriched Intravenous Lipid Emulsion

## Key facts

- **NCT ID:** NCT04078906
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12-16
- **Primary completion:** 2024-10
- **Final completion:** 2024-10
- **Target enrollment:** 384 (ESTIMATED)
- **Last updated:** 2022-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04078906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04078906, "SMOFlipid and Incidence of BPD in Preterm Infants". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04078906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*